Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Deciding between mobile and hardware wallets depends on usage and risk tolerance. This intro outlines safety considerations for both.
21,216 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When mining stocks move, gold prices often lead the dance. This article breaks down why coeur mining stock dropped, w...
A major stake sale in Albertsons by a large hedge fund sparks questions about what insiders know and how it affects t...
A newCapital Economics note warns that the current rotation in U.S. equities could be a forerunner to a broader corre...
Amazon has built a multi-engine growth machine spanning cloud, commerce, and ads. This guide explains why it could be...
Sitting on a 1.1% S&P yield can feel underwhelming. These three dividend stocks double right now offer stronger incom...
Tariff headlines keep markets guessing. This guide shows how two Vanguard index funds outperformed the S&P 500 in 202...
Looking at how applied optoelectronics (aaoi) earnings shape the stock story? This guide breaks down what to watch in...
NuScale Power has seen wild swings, but the story isn’t just nostalgia for a boom. This piece breaks down the odds of...
Sweetgreen faces a turning point after a tough year. This article examines if a 'wraps' strategy—bundled menu changes...
Monthly dividend stocks can help you smooth income and weather market swings. This deep dive explains how to spot the...
Investors woke up to a sharp move in Life360 after a strong Q4 report, but guiding headwinds sparked a sell-off. This...